3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
8
Fibrosis
4
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Mucositis
2
Lymphedema
2
Erectile Dysfunction
2
Sarcoidosis, Pulmonary
1
Prostatic Neoplasms
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pentoxifylline, Cisplatin, Nephrotoxixcity
1
Pancreatitis, Alcoholic
1
Pancreatitis
1
Pain
1
Osteoradionecrosis
1
Non-small Cell Lung Cancers
1
Neuritis
1
Neoplasms
1
Long-term Adverse Effects of Radiotherapy for Pelvic Cancer
1
Hodgkin Disease
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Capsular Contractures
1
Interventions
Pentoxifylline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pancreatitis, Alcoholic
×
Pentoxifylline
×
Clear all
NCT02487225
2019-01-23
AP
Mayo Clinic
Phase 3
Completed
83 enrolled
11 charts